Brief: Oncoarendi Therapeutics Signs Subsidy Deal For About 22 Mln Zlotys
March 6 (Reuters) - Oncoarendi Therapeutics SA OAT.WA :
* SIGNS SUBSIDY DEAL WITH NCBR FOR ABOUT 22 MILLION ZLOTYS
* SUBSIDISED PROJECT REGARDS DEVELOPMENT OF EXPERIMENTAL
CANCER
DRUG
Source text for Eikon: ID:nEM5cTchQa
Further company coverage: OAT.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments